Importantly, ELD607 has an identical mechanism of action as SPLUNC1 (Figure 3), and we propose that ELD607 will restore SPLUNC1’s immunomodulatory functions to CF and other airways [99,108]. The gene discussed is BPIFA1; the disease is cystic fibrosis.